Company Filing History:
1 out of 1 
1 out of 4 
1 out of 7 Years Active: 2018
Title: Erwin Knecht Roberto: Innovator in mTOR Inhibitors for X-ALD Treatment
Introduction
Erwin Knecht Roberto is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of X-linked adrenoleukodystrophy (X-ALD). His innovative work focuses on the use of specific mTOR inhibitors as a potential therapeutic approach for this rare genetic disorder.
Latest Patents
Erwin Knecht Roberto holds a patent for "Specific mTOR inhibitors in the treatment of X-linked adrenoleukodystrophy." This invention relates to novel uses of specific mTOR inhibitors as a medicament, particularly for the treatment of X-ALD. The patent also outlines a method for identifying compounds that may be useful in the treatment and prevention of X-ALD. He has 1 patent to his name.
Career Highlights
Throughout his career, Erwin has worked with prominent research institutions. He has been associated with the Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe and the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL). His work in these institutions has contributed to advancements in biomedical research and therapeutic development.
Collaborations
Erwin has collaborated with various professionals in his field, including Aurora Pujol Onofre. These collaborations have enhanced the research and development of innovative treatments for genetic disorders.
Conclusion
Erwin Knecht Roberto's contributions to the field of medicine, particularly through his patent on mTOR inhibitors for X-ALD, highlight his role as an innovator. His work continues to pave the way for potential advancements in the treatment of genetic disorders.